EPHA2 and intrahepatic cholangiocarcinoma: A series of in vitro and in vivo experiments demonstrated that EPHA2 mutations resulted in the phosphorylation of Ser897, independent of ligand binding, which facilitated lymphatic metastasis in ICC.